Get the Stockscreener App
2.444
6.72%
0.154
Oramed Pharmaceuticals Inc stock is traded at $2.444, with a volume of 131.41K.
It is up +6.72% in the last 24 hours and down -1.85% over the past month.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
See More
Previous Close:
$2.29
Open:
$2.29
24h Volume:
131.41K
Relative Volume:
1.35
Market Cap:
$100.05M
Revenue:
$2.70M
Net Income/Loss:
$5.53M
P/E Ratio:
22.22
EPS:
0.11
Net Cash Flow:
$-10.55M
1W Performance:
+7.67%
1M Performance:
-1.85%
6M Performance:
+5.80%
1Y Performance:
+2.69%
1-Day Range:
$2.27
$2.45
1-Week Range:
$2.21
$2.45
52-Week Range:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Name
Oramed Pharmaceuticals Inc
Sector
Industry
Phone
646-844-1164
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.44 | 95.95M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.95 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.17 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.07 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
816.48 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
308.21 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-20-21 | Initiated | Canaccord Genuity | Buy |
| Feb-09-21 | Initiated | National Securities | Buy |
| Dec-03-20 | Initiated | Alliance Global Partners | Buy |
| Mar-11-20 | Initiated | Aegis Capital | Buy |
| Sep-11-19 | Initiated | Ladenburg Thalmann | Buy |
| Dec-11-17 | Resumed | B. Riley FBR, Inc. | Buy |
| May-26-16 | Reiterated | FBR Capital | Outperform |
| Dec-01-15 | Reiterated | H.C. Wainwright | Buy |
| Nov-19-15 | Initiated | FBR Capital | Outperform |
| Apr-13-15 | Resumed | MLV & Co | Buy |
| Jan-30-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Initiated | MLV & Co | Buy |
| Dec-03-13 | Initiated | Aegis Capital | Buy |
View All
Oramed Pharmaceuticals Inc Stock (ORMP) Latest News
Oramed to launch new oral insulin trial after terminating joint venture - Investing.com
Oramed (NASDAQ: ORMP) posts $210M assets, plans one-time dividend; U.S. insulin trial - Stock Titan
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversalEarnings Performance Report & Risk Controlled Swing Alerts - newser.com
Will Oramed Pharmaceuticals Inc. stock continue upward momentumWeekly Trading Summary & Daily Volume Surge Signals - nchmf.gov.vn
How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsOptions Play & High Win Rate Trade Alerts - newser.com
What insider trading reveals about Oramed Pharmaceuticals Inc. stockWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
What recovery options are there for Oramed Pharmaceuticals Inc.Trade Performance Summary & Risk Controlled Swing Alerts - newser.com
Pattern recognition hints at Oramed Pharmaceuticals Inc. upsideJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock ideal for retirement investors2025 Performance Recap & High Accuracy Trade Alerts - newser.com
Custom watchlist performance reports with Oramed Pharmaceuticals Inc.Oil Prices & Technical Confirmation Trade Alerts - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profileWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
Why Oramed Pharmaceuticals Inc. (OJU1) stock fits value portfoliosJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
What does recent volatility data suggest for Oramed Pharmaceuticals Inc.July 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
Will Oramed Pharmaceuticals Inc. (OJU1) stock issue positive guidanceVolume Spike & Real-Time Stock Price Movement Reports - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryTrade Volume Summary & Real-Time Buy Zone Alerts - newser.com
What’s the recovery path for long term holders of Oramed Pharmaceuticals Inc.Gap Down & Weekly High Return Forecasts - newser.com
How supply chain issues affect Oramed Pharmaceuticals Inc. stockWeekly Market Report & Safe Entry Trade Signal Reports - newser.com
Visualizing Oramed Pharmaceuticals Inc. stock with heatmapsTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
Is it time to cut losses on Oramed Pharmaceuticals Inc.Market Volume Summary & AI Based Buy and Sell Signals - newser.com
Can Oramed Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Performance Recap & Safe Capital Growth Trade Ideas - nchmf.gov.vn
Can Oramed Pharmaceuticals Inc. stock deliver surprise earnings beatInsider Selling & Short-Term High Return Ideas - nchmf.gov.vn
What the Next Quarters Forecast Means for Walchandnagar Industries Limited InvestorsPrice Channel Trading & High Return Investment Plans - earlytimes.in
What is the fair value estimate for Oramed Pharmaceuticals Inc. (OJU1) stock in 2025Rate Cut & AI Enhanced Market Trend Forecasts - nchmf.gov.vn
Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):